Dillon, Deborah

Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer

Shu, S., Lin, C. Y., He, H. H., Witwicki, R. M., Tabassum, D. P., Roberts, J. M., Janiszewska, M., Jin Huh, S., Liang, Y., Ryan, J., et al. (2016) · Nature

Protein Degradation and InhibitorsChromatin Remodeling and Cancer

Cited by 632

A pathology foundation model for cancer diagnosis and prognosis prediction

Wang, X., Zhao, J., Marostica, E., Yuan, W., Jin, J., Zhang, J., Li, R., Tang, H., Wang, K., Li, Y., et al. (2024) · Nature

AI in cancer detectionRadiomics and Machine Learning in Medical Imaging

Cited by 580

Overcoming Therapeutic Resistance in HER2-Positive Breast Cancers with CDK4/6 Inhibitors

Goel, S., Wang, Q., Watt, A. C., Tolaney, S. M., Dillon, D. A., Li, W., Ramm, S., Palmer, A. C., Yuzugullu, H., Varadan, V., et al. (2016) · Cancer Cell

Advanced Breast Cancer TherapiesPI3K/AKT/mTOR signaling in cancer

Cited by 470

Impact of a pre-operative exercise intervention on breast cancer proliferation and gene expression: results from the Pre-Operative Health and Body (PreHAB) Study

Ligibel, J. A., Dillon, D., Giobbie-Hurder, A., McTiernan, A., Frank, E., Cornwell, M., Pun, M., Campbell, N., Dowling, R. J. O., Chang, M. C., et al. (2019) · Clinical Cancer Research

Cancer Risks and FactorsCancer survivorship and care

Cited by 100

Loss of SMAD4 protein expression in gastrointestinal and extra‐gastrointestinal carcinomas

Ritterhouse, L. L., Wu, E. Y., Kim, W. G., Dillon, D. A., Hirsch, M. S., Sholl, L. M., Agoston, A. T., Setia, N., Lauwers, G. Y., Park, D. Y., et al. (2019) · Histopathology

Cancer Diagnosis and TreatmentTGF-β signaling in diseases

Cited by 47

Luminal breast epithelial cells of BRCA1 or BRCA2 mutation carriers and noncarriers harbor common breast cancer copy number alterations

Williams, M. J., Oliphant, M. U. J., Au, V., Liu, C., Baril, C., O’Flanagan, C., Lai, D., Beatty, S., Van Vliet, M., Yiu, J. C., et al. (2024) · Nature Genetics

Cancer Genomics and DiagnosticsBRCA gene mutations in cancer

Cited by 34